{"id":"W4383683701","doi":"10.58931/cibdt.2023.1s0510","title":"Targeting IL23p19 using risankizumab for the management of moderate-to-severely active Crohn's disease","year":2023,"lang":"en","type":"article","venue":"Canadian IBD Today","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Ustekinumab; Medicine; Interleukin 23; Crohn's disease; Psoriasis; Inflammatory bowel disease; Monoclonal antibody; Immunology; Ulcerative colitis; Monoclonal; Disease; Internal medicine; Interleukin 17; Antibody; Inflammation; Adalimumab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001479673,0.0001582223,0.0001796638,0.0001770137,0.0004790596,0.00001573644,0.0002151484,0.00008853921,0.0001914768],"category_scores_gemma":[0.00002578662,0.0001275032,0.0001074351,0.0002870528,0.00005767605,0.00004851608,0.00004529749,0.00006254737,0.0001862582],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001744615,"about_ca_system_score_gemma":0.0002179005,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.008602603,"about_ca_topic_score_gemma":0.003833858,"domain_scores_codex":[0.9989759,0.00006027104,0.0001706159,0.0002655393,0.00003139085,0.0004962745],"domain_scores_gemma":[0.9993841,0.000129672,0.0000595683,0.0002596464,0.0000521773,0.0001148379],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.01709199,0.0004394463,0.005479998,0.001061759,0.01827676,0.002112727,0.01505647,0.04562481,0.02252895,0.02419062,0.1772795,0.670857],"study_design_scores_gemma":[0.007904549,0.0002430183,0.6539527,0.000428816,0.002913537,0.00001544645,0.00573642,0.004141015,0.02280369,0.002495986,0.2977475,0.001617324],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9921082,0.001442079,0.0005016875,0.0008379775,0.001287119,0.001305518,0.001513706,0.00006357498,0.0009401071],"genre_scores_gemma":[0.9951995,0.00006882801,0.0002072336,0.0001902309,0.00004514605,0.0001533558,0.0002394185,0.00002719763,0.003869097],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6692396,"threshold_uncertainty_score":0.9979992,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02728106468797626,"score_gpt":0.2513715419572027,"score_spread":0.2240904772692264,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}